Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / BGNE - BeiGene regains global rights to investigational anti-PD-1 antibody

BGNE - BeiGene regains global rights to investigational anti-PD-1 antibody

BeiGene Ltd.
  • BeiGene (BGNE) will get back its rights to tislelizumab from Celgene (CELG +0.4%) plus $150M ahead of Celgene's merger with Bristol-Myers Squibb.
  • More news on: BeiGene, Ltd., Celgene Corporation, Healthcare stocks news,
    • Read more ...
Stock Information
Company Name: BeiGene Ltd.
Stock Symbol: BGNE
Market: NASDAQ
Website: beigene.com
Menu
BGNE BGNE Quote BGNE Short BGNE News BGNE Articles BGNE Message Board
Get BGNE Alerts

News, Short Squeeze, Breakout and More Instantly...